https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=Madrigal_Pharmaceuticals%2C_Inc. 2026-04-05T23:13:43Z Istoricul versiunilor pentru această pagină din wiki MediaWiki 1.39.2 https://wiki.tradeville.ro/index.php?title=Madrigal_Pharmaceuticals,_Inc.&diff=429835&oldid=prev 2024-09-18T18:11:47Z

<p>Pagină nouă: Pagina dedicata companiei Madrigal Pharmaceuticals, Inc. listata cu simbolul US.MDGL ==Descriere companie== Madrigal Pharmaceuticals, Inc. (http://www.madrigalpharma.com) is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The Company’s lead product candidate, MGL-3196 (resmetirom), is a liver-directed, selective thyroid h...</p> <p><b>Pagină nouă</b></p><div>Pagina dedicata companiei Madrigal Pharmaceuticals, Inc. listata cu simbolul US.MDGL<br /> <br /> ==Descriere companie==<br /> Madrigal Pharmaceuticals, Inc. (http://www.madrigalpharma.com) is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The Company’s lead product candidate, MGL-3196 (resmetirom), is a liver-directed, selective thyroid hormone receptor-ß (THR-ß) agonist for the treatment of non-alcoholic steatohepatitis (NASH)and heterozygous familial hypercholesterolemia (HeFH). Its product pipeline also includes MGL-3745, which is used in the treatment of NASH and HeFH.<br /> <br /> ==Grafic actiuni companie==<br /> &lt;iframe key=&quot;tradeville&quot; path=&quot;graficSimbol/US.MDGL&quot; /&gt;<br /> <br /> ==Ultimele stiri despre Madrigal Pharmaceuticals, Inc. (US.MDGL)==<br /> &lt;dynamicpagelist&gt;<br /> category=US.MDGL<br /> count=10<br /> order=descending<br /> addfirstcategorydate=false<br /> &lt;/dynamicpagelist&gt;<br /> <br /> [[Categorie:US.MDGL]][[Categorie:Stiri despre companii]]</div>

Admin